Interferonβ-1b induces the expression of RGS1 a negative regulator of G-protein signaling

International Journal of Cell Biology

Volumn , Issue , 2010, Pages

  Croze, Ed ^a,c   Tran, Tiffany ^a   Paz, Pedro ^a   Velichko, Sharlene ^a   Cifrese, Jill ^a   Belur, Praveen ^a   Yamaguchi, Ken D ^a   Ku, Karin ^a   Mirshahpanah, Parham ^a   Reder, Anthony T ^b  

^a Bayer HealthCare Applied Research   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Bayer Healthcare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; INTERFERON BETA SERINE; INTERFERON RECEPTOR; RNA;

ARTICLE; B LYMPHOCYTE; CELL MIGRATION; ENZYME ACTIVITY; HUMAN; IMMUNOCOMPETENT CELL; MONOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; T LYMPHOCYTE;

EID: 79952226730     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2010/529376     Document Type: Article

References (50)

1. DeFranco A. L., Locksley R. M., Robertson M., Immunity: the immune response in infectious and inflammatory disease Immunity 2007 1st Northamptonshire, UK Oxford University Press 1 19
2. Parham P., Elements of the immune system The immune System 2004 2nd chapter 1 Oxford, UK Garland Science 1 145
3. Baggiol (Pubitemid 28207705)
4. Abbas A. K., Lichtmann A. H., Cells and tissues of the immune system Cellular and Molecular Immunology 2003 5th Philadelphia, Pa, USA Saunders 16 39
5. Gibbons L. J., Hyrich K. L., Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response BioDrugs 2009 23 2 111 124
6. Fiocchi C., Inflammatory bowel disease: etiology and pathogenesis Gastroenterology 1998 115 1 182 205 (Pubitemid 28307304)
7. Hafler D. A., Slavik J. M., Anderson D. E., O'Connor K. C., De Jager P., Baecher-Allan C., Multiple sclerosis Immunological Reviews 2005 204 208 231 (Pubitemid 40460504)
8. Horuk R., Chemokine receptors Cytokine and Growth Factor Reviews 2001 12 4 313 335 (Pubitemid 32851745)
9. Mogensen K. E., Lewerenz M., Reboul J., Lutfalla G., Uz G., The type I interferon receptor: structure, function, and evolution of a family business Journal of Interferon Cytokine Research 1999 19 10 1069 1098 (Pubitemid 29502774)
10. Russell-Harde D., Wagner T. C., Perez H. D., Croze E., Formation of a uniquely stable type I interferon receptor complex by interferon is dependent upon particular interactions between interferon and its receptor and independent of tyrosine phosphorylation Biochemical and Biophysical Research Communications 1999 255 2 539 544 (Pubitemid 29292295)
11. Croze E., Russell-Harde D., Charis Wagner T., Pu H., Pfeffer L. M., Perez H. D., The human type I interferon receptor: identification of the interferon -specific receptor-associated phosphoprotein The Journal of Biological Chemistry 1996 271 52 33165 33168 (Pubitemid 27010335)
12. Stark G. R., Kerr I. M., Williams B. R. G., Silverman R. H., Schreiber R. D., How cells respond to interferons Annual Review of Biochemistry 1998 67 227 264 (Pubitemid 28411130)
13. Reder A. T., Velichko S., Yamaguchi K. D., Hamamcioglu K., Ku K., Beekman J., Wagner T. C., Perez H. D., Salamon H., Croze E., IFN- 1b induces transient and variable gene expression in relapsing-remitting multiple sclerosis patients independent of neutralizing antibodies or changes in IFN receptor RNA expression Journal of Interferon Cytokine Research 2008 28 5 317 331 (Pubitemid 351725305)
14. Duquette P., Girard M., Despault L., DuBois R., Knobler R. L., Lublin F. D., Kelley L., Francis G. S., Lapierre Y., Antel J., Freedman M., Hum S., Greenstein J. I., Mishra B., Muldoon J., Whitaker J. N., Evans B. K., Layton B., Sibley W. A., Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial Neurology 1993 43 4 I 655 661 (Pubitemid 23121951)
15. Neer E. J., Heterotrimeric G proteins: organizers of transmembrane signals Cell 1995 80 2 249 257
16. Offermanns S., Simon M. I., Organization of transmembrane signalling by heterotrimeric G proteins Cancer Surveys 1996 27 177 198 (Pubitemid 26363829)
17. Fredriksson R., Lagerstrm M. C., Lundin L.-G., Schith H. B., The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints Molecular Pharmacology 2003 63 6 1256 1272 (Pubitemid 36627220)
18. Flower D. R., Modelling G-protein-coupled receptors for drug design Biochimica et Biophysica Acta 1999 1422 3 207 234 (Pubitemid 29512378)
19. Zhong H., Neubig R. R., Regulator of G protein signaling proteins: novel multifunctional drug targets The Journal of Pharmacology and Experimental Therapeutics 2001 297 3 837 845 (Pubitemid 32472477)
20. Cho H., Harrison K., Kehrl J. H., Regulators of G protein signaling: potential drug targets for controlling cardiovascular and immune function Current Drug Targets. Immune, Endocrine and Metabolic Disorders 2004 4 2 107 118
21. Strange P. G., Signaling mechanisms of GPCR ligands Current Opinion in Drug Discovery and Development 2008 11 2 196 202 (Pubitemid 351281059)
22. Chambers J. J., Moore L. R., Lara O., Tong X., Zborowski M., Chalmers J. J., Magnetic cell separations Laboratory Techniques in Biochemical Molecular Biology 2007 1st New York, NY, USA Elsevier Science and Technology Books 163 290
23. McDonald W. I., Compston A., Edan G., Goodkin D., Hartung H.-P., Lublin F. D., McFarland H. F., Paty D. W., Polman C. H., Reingold S. C., Sandberg-Wollheim M., Sibley W., Thompson A., Van Den Noort S., Weinshenker B. Y., Wolinsky J. S., Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis Annals of Neurology 2001 50 1 121 127
24. Gentleman R. C., Carey V. J., Bates D. M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A. J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J. Y., Zhang J., Bioconductor: open software development for computational biology and bioinformatics Genome biology 2004 5 10 R80
25. Cope L. M., Irizarry R. A., Jaffee H. A., Wu Z., Speed T. P., A benchmark for Affymetrix GeneChip expression measures Bioinformatics 2004 20 3 323 331 (Pubitemid 38262763)
26. Croze E., Ku K., Paz P., Type I interferons regulate the expression of a GTPase activating protein that controls responsiveness to chemoattractant receptors in relapsing-remitting multiple sclerosis patients Keystone Symposia, Multiple Sclerosis 2009 57
27. Johnston C. A., Siderovski D. P., Receptor-mediated activation of heterotrimeric G-proteins: current structural insights Molecular Pharmacology 2007 72 2 219 230 (Pubitemid 47124101)
28. Moratz C., Hayman J. R., Gu H., Kehrl J. H., Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in RGS1-/- mice Molecular and Cellular Biology 2004 24 13 5767 5775 (Pubitemid 38787962)
29. Denecke B., Meyerdierks A., Bttger E. C., RGS1 is expressed in monocytes and acts as a GTPase-activating protein for G-protein-coupled chemoattractant receptors The Journal of Biological Chemistry 1999 274 38 26860 26868
30. De Jager P. L., Chibnik L. B., Cui J., Reischl J., Lehr S., Simon K. C., Aubin C., Bauer D., Heubach J. F., Sandbrink R., Tyblova M., Lelkova P., Havrdova E., Pohl C., Horakova D., Ascherio A., Hafler D. A., Karlson E. W., Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score The Lancet Neurology 2009 8 12 1111 1119
31. Esposito F., Patsopoulos N. A., Cepok S., Kockum I., Lepp V., Booth D. R., Heard R. N., Stewart G. J., Cox M., Scott R. J., Lechner-Scott J., Goris A., Dobosi R., Dubois B., Rioux J. D., Oturai A. B., Sndergaard H. B., Sellebjerg F., Srensen P. S., Reunanen M., Koivisto K., Cournu-Rebeix I., Fontaine B., Winkelmann J., Gieger C., Infante-Duarte C., Zipp F., Bergamaschi L., Leone M., Bergamaschi R., Cavalla P., Lorentzen A. R., Mero I.-L., Celius E. G., Harbo H. F., Spurkland A., Comabella M., Bryneda B., Alfredsson L., Bernardinelli L., Robertson N. P., Hawkins C. P., Barcellos L. F., Beecham G., Bush W., Cree B. A.C., Daly M. J., Ivinson A. J., Aubin C., Compston A., D'Alfonso S., Haines J. L., Hauser S. L., Hemmer B., Hillert J., McCauley J. L., Oksenberg J., Olsson T., Palotie A., Peltonen L., Pericak-Vance M. A., Saarela J., Sawcer S. J., Stranger B., Boneschi F. M., Comi G., Hafler D. A., De Bakker P. I.W., De Jager P. L., IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci Genes and Immunity 2010 11 5 397 405
32. Pestka S., Langer J. A., Zoon K. C., Samuel C. E., Interferons and their actions Annual Review of Biochemistry 1987 56 727 777 (Pubitemid 17105465)
33. Calabresi P. A., Tranquill L. R., Dambrosia J. M., Stone L. A., Maloni H., Bash C. N., Frank J. A., McFarland H. F., Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon -1b Annals of Neurology 1997 41 5 669 674 (Pubitemid 27212662)
34. Panaro M. A., Acquafredda A., Sisto M., Lisi S., Maffione A. B., Mitolo V., Biological role of the N-formyl peptide receptors Immunopharmacology and Immunotoxicology 2006 28 1 103 127 (Pubitemid 43739112)
35. Vandercappellen J., Van Damme J., Struyf S., The role of CXC chemokines and their receptors in cancer Cancer Letters 2008 267 2 226 244
36. Ward S. G., Marelli-Berg F. M., Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation Biochemical Journal 2009 418 1 13 27
37. Lang K. S., Burow A., Kurrer M., Lang P. A., Recher M., The role of the innate immune response in autoimmune disease Journal of Autoimmunity 2007 29 4 206 212 (Pubitemid 350011036)
38. Nicholson L. B., Raveney B. J.E., Munder M., Monocyte dependent regulation of autoimmune inflammation Current Molecular Medicine 2009 9 1 23 29
39. Thewissen M., Stinissen P., New concepts on the pathogenesis of autoimmune diseases: a role for immune homeostasis, immunoregulation, and immunosenescence Critical Reviews in Immunology 2008 28 5 363 376
40. Plasker E. L., Interferon- -1b: a review of its use in multiple sclerosis CNS Drugs 2011 25 1 67 88
41. Martinez-Forero I., Pelaez A., Villoslada P., Pharmacogenomics of multiple sclerosis: in search for a personalized therapy Expert Opinion on Pharmacotherapy 2008 9 17 3053 3067
42. Lou J., Gasche Y., Zheng L., Giroud C., Morel P., Clements J., Ythier A., Grau G. E., Interferon- inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer Laboratory Investigation 1999 79 8 1015 1025 (Pubitemid 29400146)
43. Leppert D., Waubant E., Brk M. R., Oksenberg J. R., Hauser S. L., Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis Annals of Neurology 1996 40 6 846 852 (Pubitemid 27044602)
44. Crange A., Chazaud B., Plonquet A., Sharshar T., Poron F., Sonnet C., Raphal J.-C., Gherardi R. K., IFN- decreases adhesion and transmigration capacities of lymphocytes in Guillain-Barr syndrome Neurology 2001 57 9 1704 1706 (Pubitemid 33055494)
45. Agens F., Bosco N., Mascarell L., Fritah S., Ceredig R., Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ nave and regulatory T cells Immunology 2005 115 2 179 188 (Pubitemid 40733403)
46. Huang X., Fu Y., Charbeneau R. A., Saunders T. L., Taylor D. K., Hankenson K. D., Russell M. W., D'Alecy L. G., Neubig R. R., Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele Molecular and Cellular Biology 2006 26 18 6870 6879 (Pubitemid 44387636)
47. Bansal G., Druey K. M., Xie Z., R4 RGS proteins: regulation of G-protein signaling and beyond Pharmacology and Therapeutics 2007 116 3 473 495 (Pubitemid 350116944)
48. Hauser S. L., Oksenberg J. R., The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration Neuron 2006 52 1 61 76 (Pubitemid 44466355)
49. Croze E., Velichko S., Tran T., Betaferon Induces a Novel Alternate Start Transcript in Cells Obtained From Relapsing-Remitting Multiple Sclerosis Patients and Human Brain That is Associated with Control of Oxidative Resistance Multiple Sclerosis 2009 15 1 138
50. Gonsette R. E., Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity Journal of the Neurological Sciences 2008 274 1-2 48 53